Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics
出版年份 2020 全文链接
标题
Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics
作者
关键词
-
出版物
Pharmaceutics
Volume 12, Issue 5, Pages 440
出版商
MDPI AG
发表日期
2020-05-12
DOI
10.3390/pharmaceutics12050440
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Strategies for Tissue-Specific Drug Delivery
- (2020) Zongmin Zhao et al. CELL
- Surface-anchored framework for generating RhD-epitope stealth red blood cells
- (2020) Yueqi Zhao et al. Science Advances
- Pharmacokinetics, Biodistribution, and Pharmacodynamics of Drug Delivery Systems
- (2019) Patrick M. Glassman et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis
- (2019) Zongmin Zhao et al. Science Advances
- Erythrocytes as carriers of immunoglobulin-based therapeutics
- (2019) Weihang Ji et al. Acta Biomaterialia
- Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
- (2018) Jacob S. Brenner et al. Nature Communications
- The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity
- (2018) H. Luke Anderson et al. JOURNAL OF IMMUNOLOGY
- Immunogenicity of murine mPEG-red blood cells and the risk of anti-PEG antibodies in human blood donors
- (2017) Yevgeniya Le et al. EXPERIMENTAL HEMATOLOGY
- Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury
- (2017) Ronald Carnemolla et al. FASEB JOURNAL
- Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes
- (2017) Peter Popp Wibroe et al. Nature Nanotechnology
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease
- (2017) Novalia Pishesha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond
- (2017) Carlos H. Villa et al. TRANSFUSION MEDICINE REVIEWS
- From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis
- (2017) Thomas R. L. Klei et al. Frontiers in Immunology
- Nanomedicines: From Bench to Bedside and Beyond
- (2016) Henry Havel et al. AAPS Journal
- Pathways of protein and lipid receptor-mediated transcytosis in drug delivery
- (2016) Roland Thuenauer et al. Expert Opinion on Drug Delivery
- Drug-loaded erythrocytes: on the road toward marketing approval
- (2016) Vanessa Bourgeaux et al. Drug Design Development and Therapy
- Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches
- (2015) Aaron C. Anselmo et al. BIOMATERIALS
- Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition
- (2015) Shaojun Shi et al. CURRENT DRUG METABOLISM
- Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes
- (2015) Prabhani U. Atukorale et al. Nanoscale
- Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens
- (2015) Alizée J. Grimm et al. Scientific Reports
- Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase
- (2015) K. M. Lorentz et al. Science Advances
- Approaches to erythrocyte-mediated drug delivery
- (2014) Mauro Magnani et al. Expert Opinion on Drug Delivery
- Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application
- (2014) Huining He et al. JOURNAL OF CONTROLLED RELEASE
- Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes
- (2014) Rajesh Mukthavaram et al. JOURNAL OF CONTROLLED RELEASE
- Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes
- (2014) J. Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells
- (2013) Aaron C. Anselmo et al. ACS Nano
- Advanced drug delivery systems for antithrombotic agents
- (2013) C. F. Greineder et al. BLOOD
- Human erythrocytes as drug carriers: Loading efficiency and side effects of hypotonic dialysis, chlorpromazine treatment and fusion with liposomes
- (2013) M.E. Favretto et al. JOURNAL OF CONTROLLED RELEASE
- Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice
- (2013) Nelson S. Yew et al. MOLECULAR GENETICS AND METABOLISM
- Distearoyl Anchor-Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo
- (2013) Guixin Shi et al. Advanced Healthcare Materials
- Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells
- (2012) Rafi Chapanian et al. BIOMATERIALS
- In vivo circulation, clearance, and biodistribution of polyglycerol grafted functional red blood cells
- (2012) Rafi Chapanian et al. BIOMATERIALS
- Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis
- (2012) S. Zaitsev et al. BLOOD
- Engineering antigens for in situ erythrocyte binding induces T-cell deletion
- (2012) S. Kontos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent
- (2011) K. C. Gersh et al. BLOOD
- Microthrombosis after experimental subarachnoid hemorrhage: Time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan
- (2011) Jared M. Pisapia et al. EXPERIMENTAL NEUROLOGY
- Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation
- (2010) S. Zaitsev et al. BLOOD
- Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders
- (2010) William M. Armstead et al. JOURNAL OF NEUROCHEMISTRY
- The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound versus free fibrinolytics
- (2010) K.C. Gersh et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Improving Protein Pharmacokinetics by Engineering Erythrocyte Affinity
- (2010) Stephan Kontos et al. MOLECULAR PHARMACEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pig
- (2010) William M. Armstead et al. Pediatric Critical Care Medicine
- Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes
- (2009) Elsa Briones et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers
- (2009) Sheng-Hua Yuan et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Red Blood Cells-Coupled tPA Prevents Impairment of Cerebral Vasodilatory Responses and Tissue Injury in Pediatric Cerebral Hypoxia/Ischemia through Inhibition of ERK MAPK Activation
- (2009) William M Armstead et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile
- (2009) Juan-Carlos Murciano et al. JOURNAL OF CONTROLLED RELEASE
- L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL)
- (2009) Young Min Kwon et al. JOURNAL OF CONTROLLED RELEASE
- Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites
- (2009) Guo-Ping Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Erythrocyte-Bound Tissue Plasminogen Activator is Neuroprotective in Experimental Traumatic Brain Injury
- (2009) Sherman C. Stein et al. JOURNAL OF NEUROTRAUMA
- Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis
- (2009) S. Zaitsev et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator
- (2008) Kristina Danielyan et al. CIRCULATION
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started